AlphaYouGN
Insider selling
Gilmore Neil O'Neill sold $42K of Editas Medicine, Inc. (EDIT) stock
Gilmore Neil O'Neill, CEO of Editas Medicine, Inc. (EDIT), sold 15,380 shares of EDIT stock worth $42K, per an SEC Form 4 filed Jun 5, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 3, 2026, 2 days before it was made public.
EDIT has moved +1.8% since the trade date, from $2.78 to $2.83 (Sep 21, 2026 close).
- Traded
- Jun 3, 2026
- Disclosed
- Jun 5, 2026
- Filing delay
- 2 days
- Price since
- +1.8%
- Role
- CEO
- Source
- SEC Form 4
More EDIT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.